In silico identification and deorphanisation of an allatostatin C GPCR system in the cephalopod Octopus vulgaris reveals two receptors with distinct potency

This study identifies and characterizes a conserved allatostatin C neuropeptide system in the octopus *Octopus vulgaris*, revealing a single peptide that differentially activates two distinct receptors with broad tissue distribution, suggesting a critical role in sensory processing and nociception with significant implications for cephalopod welfare.

The Gist

Imagine the body of an octopus as a bustling, high-tech city. In this city, there are millions of tiny messengers (neuropeptides) running around, delivering notes to different buildings (cells) to tell them what to do—whether to digest food, fight an infection, or feel pain.

For a long time, scientists knew about the "mayor's office" (the brain) and some of the main roads, but they were missing a specific, crucial delivery service in the octopus city: the Allatostatin C system.

Here is what this paper discovered, translated into everyday language:

1. The Missing Puzzle Pieces

Scientists have known about Allatostatin C in insects (like flies and beetles) for years. It's like a universal "stop" or "calm down" signal. But when they looked at octopuses, they couldn't find the delivery trucks (receptors) or the specific notes (peptides) that make this system work. It was like knowing a city should have a fire department, but you couldn't find the fire trucks or the fire stations.

This study finally found them in the common octopus (Octopus vulgaris). They discovered:

• One Master Note: A single type of message (the peptide) that the octopus uses.
• Two Different Locks: Two different types of receptors (locks) that the message can open.

2. The "Master Key" and the "Two Locks"

Think of the Allatostatin C peptide as a Master Key.
The researchers found that this one key fits into two different locks (receptors) in the octopus's body, which they named OvAstCR1 and OvAstCR2.

• The "VIP" Lock (OvAstCR1): This lock is very sensitive. It opens easily with just a tiny tap of the key. It's like a VIP entrance that reacts to the slightest signal.
• The "Standard" Lock (OvAstCR2): This lock is much stiffer. It needs a much stronger push (100 times more key) to open.

The scientists tested this in a lab by putting these "locks" into human cells and seeing how they reacted when the octopus "key" was inserted. The VIP lock reacted strongly; the standard lock needed a lot more help.

3. The "Swiss Army Knife" of the Body

Where are these locks located? Everywhere.
The researchers checked the octopus's brain, its arms, its stomach, its immune system, and even its blood cells. They found the message and the locks in almost every major district of the city.

• In the Stomach: It likely helps control digestion (telling the stomach when to slow down or speed up).
• In the Immune System: It might help the octopus fight off infections.
• In the Brain and Arms: This is the most exciting part. Because these locks are found in the sensory parts of the body (like the suckers on the arms) and the brain, they likely play a huge role in how the octopus feels pain.

4. The "Pain" Connection (Why This Matters)

Here is the big picture: In humans, we have a famous pain-killing system called the Opioid System (think morphine or endorphins). For a long time, scientists thought octopuses didn't have anything like this, which led to debates about whether octopuses can actually feel pain or just react to it.

However, this study found that the octopus Allatostatin C system is evolutionarily related to our human opioid system. They are distant cousins on the family tree of life.

• The Analogy: Imagine that in the human family, we have a "Pain Relief" button. In the insect family, they have a similar "Pain Relief" button called Allatostatin C. This study shows that the octopus also has this button, and it's wired into their brain and nervous system just like ours.

5. The "Twist" in the Key

The researchers also found that the octopus message works best when it is "twisted" into a specific shape (a ring with a bridge). If the message is straight and floppy, it doesn't work as well. This suggests that the octopus has a very precise way of packaging these messages to ensure they get delivered correctly.

The Bottom Line

This paper is a breakthrough because it proves that octopuses have a sophisticated, built-in system for managing pain and regulating their bodies, which is closely related to the systems we have in our own bodies.

Why should you care?
Because octopuses are now protected by laws in Europe and the UK regarding how they are treated in research. Knowing that they have a biological system specifically designed to handle pain (like the "VIP lock" in their brain) gives scientists and lawmakers strong evidence that we must treat these intelligent creatures with extreme care and respect. We aren't just studying a weird animal; we are studying a fellow creature with a complex internal world of feelings.

Technical Summary

1. Problem Statement

Neuropeptide signaling is fundamental to animal physiology, yet its investigation in cephalopods remains limited despite their complex, centralized nervous systems and advanced behavioral capabilities. Specifically, the allatostatin C (AstC) system, a conserved invertebrate signaling pathway involved in development, feeding, immunity, and nociception (pain modulation), had not been functionally characterized in cephalopods. While in silico predictions existed for other molluscs, no study had successfully identified the endogenous AstC peptide and its cognate receptors in Octopus vulgaris, nor demonstrated their functional interaction. This gap hinders the understanding of cephalopod physiology and their potential capacity for pain perception, a critical factor in their inclusion under European animal welfare legislation.

2. Methodology

The study employed a multi-disciplinary approach combining bioinformatics, molecular biology, and pharmacology:

• In Silico Analysis:

  • Receptor Identification: The authors analyzed the O. vulgaris genome (Destanović et al., 2023) to identify candidate G-protein coupled receptors (GPCRs). They utilized BLAST searches against known invertebrate AstC receptors and performed phylogenetic clustering (using CLANS and IQ-TREE) to classify candidates within the Rhodopsin family (Class A GPCRs), specifically looking for relationships with opioid (OPR) and somatostatin (SSR) receptors.
  • Peptide Identification: A search for AstC precursors was conducted using conserved motifs (signal peptides, dibasic cleavage sites, and cysteine residues) against the O. vulgaris genome.
  • Genomic Mapping: Transcript sequences were aligned to the genome assembly to determine chromosomal location and intron/exon structure.

• Experimental Validation (Tissue Distribution):

  • Sample Collection: Tissues were collected from three adult O. vulgaris specimens, including central nervous system regions (supra- and sub-oesophageal masses, optic lobes), peripheral ganglia, sensory-motor tissues (arms, suckers), and visceral/immune tissues (digestive gland, stomach, white bodies, haemocytes).
  • PCR Analysis: Endpoint PCR was performed on cDNA derived from these tissues to map the expression patterns of the identified peptide precursor (OvAstC) and its two receptors (OvAstCR1 and OvAstCR2).

• Functional De-orphanisation (Receptor Activation):

  • Heterologous Expression: The coding sequences for OvAstCR1 and OvAstCR2 were codon-optimized and expressed in HEK293G5A cells stably expressing the Ca²⁺-sensitive photoprotein aequorin.
  • Peptide Synthesis: The mature OvAstC peptide (sequence: AVITACYFQAVSCY) was synthesized in two forms: cyclised (with a disulfide bridge between cysteines) and non-cyclised.
  • Calcium Assay: Cells were stimulated with varying concentrations of the peptides. Activation was measured via luminescence resulting from intracellular Ca²⁺ release, allowing for the calculation of EC₅₀ values and potency comparisons.

3. Key Contributions

• First Identification in Cephalopods: This is the first study to identify and functionally validate a complete AstC signaling system (one peptide and two receptors) in a cephalopod.
• Discovery of Receptor Duplication: The study revealed that O. vulgaris possesses two distinct AstC receptors (OvAstCR1 and OvAstCR2), whereas many other invertebrate lineages possess only one.
• Phylogenetic Context: It confirms that cephalopod AstC receptors are evolutionary orthologues of vertebrate opioid receptors and paralogues of somatostatin receptors, placing them within a specific Class A GPCR cluster.
• Functional De-orphanisation: The study experimentally proved that the predicted endogenous peptide activates both receptors, resolving the "orphan" status of these GPCRs.

4. Key Results

• Receptor Characterization:

  • Structure: Both OvAstCR1 and OvAstCR2 are Class A GPCRs with 7 transmembrane domains, conserved motifs (DRY, NPILY), and specific phosphorylation sites.
  • Genomics: Both receptors are intronless genes located on different chromosomes (Chr 23 and Chr 24). The peptide precursor (OvAstC) is located on Chromosome 12 and contains two exons and one large intron.
  • Phylogeny: Phylogenetic analysis places OvAstCRs in a distinct branch of invertebrate AstC receptors, closely related to vertebrate OPRs and SSRs.

• Peptide Characterization:

  • A single precursor gene was identified encoding a 14-amino acid mature peptide: AVITACYFQAVSCY.
  • The peptide contains two cysteines essential for a disulfide bridge. A unique feature in cephalopods is the substitution of a conserved Asparagine (N) with a Glutamine (Q) at the third position after the first cysteine.
  • The mature peptide sequence is 100% identical across all analyzed cephalopod species (O. vulgaris, O. bimaculoides, Sepia, etc.).

• Tissue Distribution:

  • Broad Expression: Both the peptide and receptors are widely expressed across the nervous system (central brain, ganglia, arms, suckers), digestive system (stomach, intestine, glands), and immune system (white bodies, haemocytes).
  • This suggests a pleiotropic role involving sensory processing, digestion, and immunity.

• Functional Potency (De-orphanisation):

  • Both receptors were activated by the synthetic OvAstC peptide in a dose-dependent manner.
  • Cyclisation Matters: The cyclised form of the peptide showed significantly higher affinity (10-fold lower EC₅₀) than the non-cyclised form for both receptors.
  • Receptor Specificity: There is a 100-fold difference in potency between the two receptors. OvAstCR1 is highly sensitive (EC₅₀ ≈ 2.8 × 10⁻⁸ M), while OvAstCR2 is significantly less sensitive (EC₅₀ ≈ 3.5 × 10⁻⁶ M).
  • The authors hypothesize that OvAstCR2 may require heterodimerization with OvAstCR1 or function under different physiological concentration regimes.

5. Significance

• Evolutionary Insight: The findings highlight the evolutionary relationship between invertebrate AstC systems and the vertebrate opioid/somatostatin systems, suggesting an ancient, shared mechanism for regulating physiological states.
• Nociception and Welfare: Given the established role of AstC in antinociception (pain suppression) in insects and its evolutionary link to vertebrate opioids, the presence of this system in the central and peripheral nervous systems of O. vulgaris provides a strong molecular basis for investigating pain perception in octopuses. This supports the precautionary principle used in European legislation regarding cephalopod welfare in research.
• Physiological Complexity: The broad tissue distribution and dual-receptor system suggest that AstC signaling in octopuses is a versatile modulator of complex behaviors, including feeding, immune response, and sensory processing, warranting further investigation into its role in cephalopod neurobiology.